Testing Salovum and SPC Flakes for Brain Tumor Swelling
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 79 years old.
- You have a brain tumor (either starting in the brain or spread from elsewhere) that is causing swelling and symptoms.
- You are awake and alert (Glasgow Coma Scale score of 14 or 15, meaning you can follow commands and talk).
- You are well enough to be up and about (ECOG performance status 0, 1, or 2).
- You are already taking or plan to start cortisone medicine for the brain swelling.
- You do not have an allergy to eggs, and your brain scan does not show a large shift of the midline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an “antisecretory factor” treatment in people with grade 4 glioblastoma (or astrocytoma). It aims to see whether it can improve outcomes when used alongside planned cancer treatments after surgery.
This trial tests if Salovum, a special egg yolk product, can improve oxygen levels and reduce pressure and inflammation in the brain for people with a suspected glioblastoma. It involves a biopsy before treatment starts.
This early-stage trial tests whether a new oral medication called gallium maltolate can help slow or shrink glioblastoma (a serious brain tumor) that has come back after initial treatment. The study enrolls patients who have already had standard brain tumor treatment and whose tumors are growing again.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This Phase 1 trial tests a new cancer drug (WSD0628) given with radiation for people whose high-grade glioma has returned after prior treatment. The goal is to find a safe dose and see how well the treatment works in this situation.
This trial tests a special MRI technique to help surgeons remove more of a glioblastoma brain tumor during surgery. The goal is to see if this approach helps people live longer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.